| ||Audit Committee||Compensation Committee||Nominating and Governance Committee|
|Harry A. George |
|Harry A. George|
Mr. George has served on our board of directors since 2002 and served as the chairman of our board of directors from December 2007 until September 2013. Mr. George co-founded Solstice Capital, a venture capital firm, in 1995 and serves as its managing general partner. Mr. George has served as a member of the board of directors of a number of private and public companies and is currently serving on the boards of directors of Calimmune, Inc., Tempronics, Inc., Medipacs, Inc., Post.Bid.Ship, Inc., ...
|| || |
|Donnie (Don) M. Hardison |
|Donnie (Don) M. Hardison|
Mr. Hardison has served on our board of directors since May 2016. In April 2016, he founded and serves as the sole proprietor of DMH Consulting, a management consulting firm. Between April 2010 and March 2016, Mr. Hardison was the President and Chief Executive Officer of Good Start Genetics, a medical device company. For more than 20 years prior to that, Mr. Hardison held a number of executive and senior management positions at companies including Laboratory Corporation of America, or LabCorp...
|James (Jim) T. LaFrance |
|James (Jim) T. LaFrance|
Mr. LaFrance has served on our board of directors since December 2015. Mr. LaFrance has almost thirty years of diagnostic industry experience working since January 2015 as a sales, marketing, strategy development and commercial operational management consultant for LaFrance Consulting LLC, a firm he founded. He served as interim Chief Executive Officer of Vermillion, Inc. (NASDAQ: VRML), a bioanalytics service provider, from April 2014 to December 2014, where he also has served as chairman of ...
|Lee R. McCracken |
|Lee R. McCracken|
Mr. McCracken has served on our board of directors since October 2015. Mr. McCracken currently is Chairman of Global Medical and Research Technologies, a company focused on solutions for organ transplantation and regenerative medicine therapies, a position he has held since May 2016. From April 2014 to May 2016, Mr. McCracken was Chief Executive Officer of Gensignia Life Sciences, Inc. Prior to that, from April 2013 to March 2014, he served as a strategic and restructu...
|Lewis (Lew) J. Shuster |
|Lewis (Lew) J. Shuster|
Mr. Shuster has served on our board of directors since March 2014. In 2002, Mr. Shuster founded Shuster Capital, a strategic and operating advisor to and angel investor in life science companies, and has served as its chief executive officer since that time. From June 2003 to November 2007, Mr. Shuster served as chief executive officer of Kemia, Inc., a drug discovery and development company. From February 2000 to December 2001, Mr. Shuster held various operating executive positions at Invitroge...
|| || |